Intensive Monitoring Study on Tyvyt

Condition:   Relapsed or Refractory Classical Hodgkin's Lymphoma Intervention:   Sponsor:   Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting

Source: ClinicalTrials.gov - January 23, 2020 Category: Research Source Type: clinical trials